| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 267,469 | 269,971 | 273,533 | 347,321 | | Cost of Revenue | 118,120 | 117,100 | 116,644 | 152,381 | | | Gross Profit | 149,349 | 152,871 | 156,889 | 194,940 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 115,049 | 115,367 | 115,564 | 131,879 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 6,779 | 6,743 | 6,874 | 7,280 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 27,521 | 30,761 | 34,451 | 55,781 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (127) | (1,132) | (1,246) | 3,255 | | Earnings Before Interest And Taxes | 27,394 | 29,629 | 33,205 | 59,031 | | Interest Expense | 4,914 | 4,011 | 4,180 | 7,718 | | Income Before Tax | 22,480 | 25,618 | 29,025 | 51,313 | | Income Tax Expense | 2,413 | 8,433 | 9,029 | 17,672 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 20,067 | 17,185 | 19,996 | 33,646 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 20,067 | 17,185 | 19,996 | 33,646 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $20,067 | $17,185 | $19,996 | $33,646 |
|
0.34% Nasdaq 
Income Statement
